• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • Latest
  • Videos
  • Series
  • E-Newsletters
    • Fat Tail Daily
    • James Cooper’s Mining Memo
    • The Daily Reckoning Australia
  • Categories
    • Commodities
    • Macro
    • Market Analysis
    • Small Caps
    • Technology
  • Investment Guides
  • Premium Services
  • Editors
  • About
  • Contact Us
Fat Tail Daily
Subscribe
  • Home
  • Latest
  • Videos
  • E-Newsletters
  • Premium Services
Latest ASX News

Will Cellmid Bounce Back from Its Trading Halt? (ASX:CDY)

Like 0

By Carl Wittkopp, Monday, 30 March 2020

Cellmid Ltd. [ASX:CDY], an Australian based biotechnology company, went into a trading halt on 20 March 2020 after falling to a close share price the previous day of $0.09.

Cellmid Ltd. [ASX:CDY], an Australian based biotechnology company, went into a trading halt on 20 March 2020 after falling to a close price the previous day of $0.09. The trading halt was at the request of Cellmid, pending it releasing an announcement.

 

ASX CDY - Cellmid Share Price

Source: Optuma

Sitting within the microcap sector with a market cap of just $9.56 million, Cellmid had experienced a drop in share price since May 2018, falling from $0.57 to find support at $0.16. This was until the coronavirus gripped the world and the Cellmid share price entered free fall as investors aggressively de-risked.

ASX CDY - Cellmid Share Price Chart 2

 

Source: Optuma

‘The Coronavirus Portfolio’ The two-pronged plan to help you deal with the financial implications of COVID-19. Download your free report

What did Cellmid announce?

Friday was a busy day for Cellmid with three announcements being made that are impacting its future. First was the announcement of a supply agreement being made for a COVID-19 rapid diagnostic test. The test is available immediately and is suitable as a bedside test can be used in hospitals, nursing homes, schools, etc. according to the company.

Given the current climate around the world this is important for Cellmid. Further announcements were made with a market update on COVID-19 and notice to lift the trading halt.

Cellmid trading halt ends and its share price goes flying

Cellmid is back in action now, and has jumped a staggering 177% at the time of writing up to $0.27. The new agreements in place appear to have given investors reasons for renewed confidence.

ASX CYD - Cellmid Share Price Chart

Source: Optuma

With the Cellmid price now rocketing up on the new announcements, how high can it go? Cellmid has historical resistance levels at $0.32 and $0.36 but if it pushed through these, the next historical level is $0.46, can Cellmid get up there?

More updates from the company will provide some clarity.

If you are looking for other companies driving coronavirus solutions, download our free report called ‘The Coronavirus Porfolio.’ It discusses the two ‘asset groups’ that could be poised to benefit in this crisis. Meanwhile, one of the ‘solutions’ stocks is up more than 35% today, at time of writing.

Regards,

Carl Wittkopp,

For Money Morning

All advice is general advice and has not taken into account your personal circumstances.

Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

Comments

Subscribe
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments
Carl Wittkopp

Carl’s Premium Subscriptions

Publication logo
Fat Tail Investment Research

Latest Articles

  • But lithium ain’t one
    By Lachlann Tierney

    Lithium’s been left for dead, but sentiment has turned. Lachlann Tierney shows you why this “specialty chemical” says it could be gearing up for one last explosive run.

  • Part 1: A Commodity Deep Dive; Uncovering the Stinkers vs Opportunities
    By James Cooper

    In Part 1 of this series, James Cooper sits down with Greg Canavan for a Commodity Deep Dive; uncovering the Stinkers vs Opportunities in the market.

  • Offense wins elections, defence wins markets
    By Lachlann Tierney

    Australia’s economy is wheezing and the ASX defensives are running hot, but with US IPOs booming and commodity tailwinds building, the real action might be hunting bargains in beaten-down small-caps.

Primary Sidebar

Latest Articles

  • But lithium ain’t one
  • Part 1: A Commodity Deep Dive; Uncovering the Stinkers vs Opportunities
  • Offense wins elections, defence wins markets
  • What does the rise of One Nation mean for your stocks?
  • April micro-cap flashback

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988